Handelsbanken Fonder’s Nu Skin NUS Stock Holding History

Handelsbanken Fonder’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,516	Closed	-$173K	–	1570
2024 Q1	$173K	Hold	12,516	–	–	﹤0.01%	1529
2023 Q4	$243K	Buy	+12,516	New	+$231K	﹤0.01%	1467
2023 Q3	–	Sell	-6,916	Closed	-$230K	–	1575
2023 Q2	$230K	Hold	6,916	–	–	﹤0.01%	1454
2023 Q1	$272K	Buy	+6,916	New	+$288K	﹤0.01%	1334
2022 Q4	–	Sell	-10,516	Closed	-$351K	–	1586
2022 Q3	$351K	Hold	10,516	–	–	﹤0.01%	1154
2022 Q2	$455K	Sell	10,516 -400	-4%	-$18.4K	﹤0.01%	1078
2022 Q1	$523K	Hold	10,916	–	–	﹤0.01%	1174
2021 Q4	$554K	Sell	10,916 -4,100	-27%	-$182K	﹤0.01%	1276
2021 Q3	$608K	Buy	15,016 +3,700	+33%	+$187K	﹤0.01%	1221
2021 Q2	$641K	Buy	11,316 +1,400	+14%	+$79.7K	﹤0.01%	1199
2021 Q1	$524K	Hold	9,916	–	–	﹤0.01%	1175
2020 Q4	$542K	Sell	9,916 -3,000	-23%	-$158K	﹤0.01%	1118
2020 Q3	$647K	Hold	12,916	–	–	﹤0.01%	878
2020 Q2	$494K	Buy	+12,916	New	+$415K	﹤0.01%	967
2019 Q3	–	Sell	-150,000	Closed	-$7.4M	–	190
2019 Q2	$7.4M	Buy	150,000 +30,000	+25%	+$1.53M	0.14%	146
2019 Q1	$5.74M	Buy	+120,000	New	+$7.27M	0.11%	150

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Handelsbanken Fonder's NUS Position: Q2 2024 in Review

Handelsbanken Fonder sold out of Nu Skin (NUS) in Q2 2024, closing a stake of 12,516 shares — an estimated $173K sold.

Handelsbanken Fonder first reported a position in NUS in Q1 2019 and held it in 16 quarters. The position peaked at $7.4M in Q2 2019. 202 funds tracked by Wall St. Rank hold NUS as of Q2 2024.

Handelsbanken Fonder reported no remaining Nu Skin position as of Q2 2024 after selling out during the quarter.
Handelsbanken Fonder sold 12,516 Nu Skin shares in Q2 2024, an estimated $173K.
Handelsbanken Fonder first reported a position in Nu Skin in Q1 2019 and held it in 16 quarters.
Handelsbanken Fonder's Nu Skin position peaked at $7.4M in Q2 2019.
202 funds tracked by Wall St. Rank held Nu Skin as of Q2 2024.

Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.